Vice President of Business Development (New York)

Radiopharmaceuticals are one of the fastest-growing and most strategically active segments in biotech and Actinium Pharmaceuticals (NYSE: ATNM) is at the forefront.

Actinium is building first-in-class targeted radiotherapies by uniquely integrating deep radiochemistry expertise with cancer biology insight. Our pipeline spans solid tumors and hematologic malignancies and includes multiple platform-level partnering opportunities across alpha-emitter therapeutics, combinations, conditioning agents, and manufacturing IP.

This is a hands-on, high-impact VP-level role working directly with the CEO and executive team to shape Actinium’s external strategy from licensing and collaborations to transformative strategic transactions.

If you want to help define how a next-generation radiopharmaceutical company partners, scales, and creates value, this role puts you at the center of it.

The Opportunity

As Vice President, Business Development, you will lead and execute Actinium’s partnering and transaction strategy across:

• Out-licensing, in-licensing, and strategic collaborations
• Platform and asset-level partnerships
• Select M&A and structured transactions
• Strategic evaluations supporting pipeline expansion and value creation

You will own opportunities end-to-end from sourcing and diligence through negotiation and close while serving as a senior external face of the company to partners, investors, and collaborators.

Key Responsibilities

• Partner with the CEO and Executive Team to define and execute Actinium’s business development strategy, with a strong emphasis on out-licensing
• Identify, evaluate, and pursue partnering opportunities aligned with scientific, clinical, and corporate objectives
• Lead deal execution: business cases, valuation and financial modeling, scenario planning, diligence, structuring, negotiation, and contract execution
• Serve as Actinium’s primary BD representative at partnering conferences, scientific meetings, and industry events
• Own competitive intelligence and market landscape analysis; keep senior leadership informed of key developments
• Lead cross-functional diligence teams (research, clinical, CMC, commercial, legal)
• Prepare and present strategic recommendations to senior management and the Board
• Collaborate closely with Research and Clinical teams to shape externally facing partnering narratives
• Provide BD input to internal programs, identifying gaps and partnership-based solutions

What You Bring

• 10+ years of progressive experience in biotech/pharma business development
• Bachelor's degree required; MBA and/or advanced scientific degree strongly preferred.
• Proven track record of sourcing, structuring, negotiating, and closing in- and out-licensing deals
• Strong command of asset valuation, financial modeling, and ROI analysis
• Deep understanding of drug development, preferably in oncology
• Credibility with senior executives and a strong industry network
• Ability to translate complex science into compelling strategic narratives
• Comfortable operating autonomously while partnering closely with senior leadership

Why Actinium

• Differentiated alpha-emitter platform with 250 patents and proprietary Ac-225 manufacturing capabilities
• Multiple first-in-class and platform-level partnering opportunities
• Direct exposure to the C-suite, Board, and strategic decision-making
• Competitive compensation including base, bonus, equity, 401(k) match, and comprehensive benefits